Abstrax and Western Washington University Unveil Groundbreaking Research Paper on CBD and Terpene Blends for Autism Spectrum Disorder

Researchers anticipate findings will ignite further investigations and establish a pathway toward more effective treatments for individuals on the autism spectrum. TUSTIN, Calif., Jan. 29, 2024 /PRNewswire-PRWeb/ -- Abstrax, an industry leader in the study and production of cannabis and...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Tags: MAT Source Type: news